ProgramME
(CEST time)
Welcome and opening
TUESDAY 25th | 09:00 - 09:01
Martin Wilks, Switzerland, and Paul Dargan, United Kingdom
Martin Wilks, Switzerland, and Paul Dargan, United Kingdom
Add to calendar2021-05-25 09:00 2021-05-25 09:01 Europe/Madrid Welcome and opening Martin Wilks, Switzerland, and Paul Dargan, United KingdomEAPCCT 2021
Session 1
TUESDAY 25th | 09:01 - 10:30
Moderators: Martin Wilks, Switzerland, and Paul Dargan, United KingdomAdd to calendar2021-05-25 09:01 2021-05-25 10:30 Europe/Madrid Session 1 Moderators: Martin Wilks, Switzerland, and Paul Dargan, United KingdomEAPCCT 2021
09:01-09:30 | In silico studies: Modelling drug-induced liver injury using machine learning Felix Hammann, University Hospital Bern, Switzerland |
09:30 -10:00 | Use of in vitro studies for prediction of clinical NPS toxicity Dino Lüthi, Medical University of Vienna, Austria |
10:00 -10:30 | Animal models to understand the mechanisms of toxicity and optimise poisoning management Bruno Mégarbane, Paris-Diderot University, France |
- Explain the potential and limitations of machine learning and cheminformatics for drug induced liver injury.
- Name at least one advantage and one disadvantage of in vitro research as predictor of the clinical toxicity of NPS.
- To understand how experimental animal models are designed and to which level they contribute to understand toxicity in humans.
Rest break
TUESDAY 25th | 10:30 - 11:00
Add to calendar2021-05-25 10:30 2021-05-25 11:00 Europe/Madrid Rest break Rest break EAPCCT 2021
Session 2
TUESDAY 25th | 11:00 - 12:30
Moderators: Bruno Megarbane, France and Katrin Faber, SwitzerlandAdd to calendar2021-05-25 11:00 2021-05-25 12:30 Europe/Madrid Session 1 Moderators: Bruno Megarbane, France and Katrin Faber, SwitzerlandEAPCCT 2021
11:00 -11:30 | Genomics, pharmacogenomics and genotyping, an overview for the clinical toxicologist Alexander Jetter, University Hospital Zürich, Switzerland |
11:30 -12:00 | Identifying exposure biomarkers with metabolomics: the example of dioxin Serge Rudaz, Université de Genève, Switzerland |
12:00 -12:30 | Pharmacokinetic-pharmacodynamic modelling in clinical toxicology Lucie Chevillard, Paris Descartes University, France |
- Describe the opportunities and the limits of pharmacogenomics in patient care.
- Know how metabolomic approaches could be useful to tackle the impact of toxicant such as acute dioxin exposure on human metabolism.
- Learn the interest of different methods of pharmacokinetics analysis and how to relate PK to the markers of intoxication (pharmacodynamic) to better understand the possible mechanisms involved.
Lunch break
TUESDAY 25th | 12:30 - 13.45
Add to calendar2021-05-25 12:30 2021-05-25 13:45 Europe/Madrid Lunch break Lunch breakEAPCCT 2021
Session 3
TUESDAY 25th | 13:45 - 15:15
Moderators: Evangelia Liakoni, Switzerland, and Geert Verstegen BelgiumAdd to calendar2021-05-25 13:45 2021-05-25 15:15 Europe/Madrid Session 3 Moderators: Eva Liakoni, Switzerland, and Geert Verstegen BelgiumEAPCCT 2021
13:45 -14:15 | Cell cultures: In vitro human cell cultures to predict drug toxicity Dirk Steinritz, Institut für Pharmakologie und Toxikologie der Bundesweh, Münich, Germany |
14:15 -14:45 | A general roadmap to investigate the main mechanisms of mitochondrial toxicity Bernard Fromenty, France |
14:15 -15:15 | Organ chips: principles and applications for clinical toxicology Pierre-Jean Ferron, INSERM, Rennes, France |
- Explain the benefit but also the limitations of in vitro cell culture models for predicting acute drug toxicity.
- Describe how xenobiotics disrupt mitocondrial metabolic pathways and the methods of investigation for these.
- Overview of the different models of organ on chips and organoids used to identify toxicity mechanism: from the clinical case to the cell biology laboratory.
Rest break
TUESDAY 25th | 15:15 - 15:45
Add to calendar2021-05-25 15:15 2021-05-25 15:45 Europe/Madrid Rest break Rest breakEAPCCT 2021
Session 4
TUESDAY 25th | 15:45 - 17:15
Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaAdd to calendar2021-05-25 15:45 2021-05-25 17:15 Europe/Madrid Session 4 Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaEAPCCT 2021
15:45-16:15 | Imaging in neuropharmacology: applications to clinical toxicology Nicholas Tournier, CEA, Orsay, France |
16:15-16:45 | Neuro-electrophysiology - principles and applications in organophosphate poisoning Tharaka Dassanayake,University of Peradeniya, Sri Lanka |
16:45-17:15 | Understanding individual differences from big data analysis of patient records Heikki Nikkanen, Mount Auburn Hospital, Boston, USA |
- Outline how PET imaging and specific biomarkers may be utilised to study kinetics and interactions in the CNS.
- Outline the basis of neuroelectrophysiological tests that assess peripheral nerves, neuromuscular junctional transmission and the central nervous system in organophosphate poisoning.
- Describe the strengths and weaknesses of manipulation of large data sets for meaningful research in toxicology.
End of Precongress symposium 2021
TUESDAY 25th | 17:15
Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaAdd to calendar2021-05-25 17:15 2021-05-25 17:30 Europe/Madrid End of Precongress symposium 2021 Moderators: Laura Hondebrink, The Netherlands and Piotr Kabata, PoloniaEAPCCT 2021
WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM
WEDNESDAY 26th | 08:45 - 09:00
Hosts: Horst Thiermann, EAPCCT PresidentLotte Hoegberg, EAPCCT/SMC Chair
Add to calendar2021-05-26 08:45 2021-05-26 09:00 Europe/Madrid WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM Hosts: Thiermann, EAPCCT President Lotte Hoegberg, EAPCCT/SMC Chair EAPCCT 2021
CAUSTIC INGESTION SYMPOSIUM
WEDNESDAY 26th | 09:00 - 11:10
Moderators: Ingrid Berling, Australia and Davide Lonati, ItalyAdd to calendar2021-05-26 09:00 2021-05-26 11:10 Europe/Madrid CAUSTIC INGESTION SYMPOSIUM Moderators: Ingrid Berling, Australia and Davide Lonati, ItalyEAPCCT 2021
09:00-09:20 | Epidemiology of caustic ingestions in children and adults Maren Hermans-Clausen, University Hospital, Freiburg, Germany |
09:20-09:40 | The role of CT in the assessment of oral caustic injury Pierre Cattan, Saint-Louis Hospital, Paris, France |
09:40-10:00 | The role of endoscopy in the assessment of oral caustic injury Filippo Torroni, Bambino Gesu' Children's Hospital, Rome, Italy |
10:00-10:20 | Risk factors for oesophageal stricture in alkali ingestion in children Viorela Nitescu, Bucharest, Romania (2020- Abstract 199) |
10:20-10:40 | Effectiveness of endoscopic application of human collagen Type 1 in the treatment of oesophageal chemical burns Anastasia Yu Simonova, Moscow, Russia (2021- Abstract 293) |
10:40-11:00 | Management of caustic injury and the indications for surgical intervention Wolfram Kluwe, University Hospital, Freiburg, Germany |
11:00-11:10 | Questions & Answers to the Caustic Ingestion Symposium speakers |
At the end of this session the audience should be able to:
- Describe factors influencing outcome of caustic ingestions regarding patterns of exposure, characteristics of agent involved and age of exposed patients.
- Outline the potential benefits of CT in the emergency management of caustic injuries and discuss the optimal use of endoscopy in the emergency management of caustic injuries in children.
- Explain the main points of the pathophysiology of caustic injuries and describe the management in acute situations and in the follow up.
Rest break and AUTHORS WITH POSTERS (Morning grouping)
WEDNESDAY 26th | 11:10 - 11:40
Add to calendar2021-05-26 11:10 2021-05-26 11:40 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Morning grouping) Rest break and AUTHORS WITH POSTERS (Morning grouping)EAPCCT 2021
ORAL PLATFORM AND SHORT ORAL PRESENTATIONS
WEDNESDAY 26th | 11:40 - 12:30
Moderators: Maren Hermans-Clausen Germany and Patricia Casey, IrelandAdd to calendar2021-05-26 11:40 2021-05-26 12:30 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Maren Hermans-Clausen Germany and Patricia Casey, IrelandEAPCCT 2021
11:40-11:50 | Characteristics and clinical features of patients attending UK emergency departments with analytically-confirmed exposure to the synthetic cannabinoid MDMB-4EN Pinaca Simon Hl Thomas, Newcastle, United Kingdom (2021- Abstract 294) |
11:50-12:10 | Changing patterns of synthetic cannabinoid receptor agonists encountered in UK emergency departments Simon Hl Thomas, Newcastle, United Kingdom (2021- Abstract 295) |
12:10-12:20 | Patterns of teenage heroin exposures reported to the US poison centres Saumitra Vijay Rege, Charlottesville, Virginia, USA (2021- Abstract 296) |
12:20-12:30 | Questions & Answers to the Oral platform and Short Oral Presentation speakers |
AUTHORS WITH POSTERS (Lunchtime grouping)
WEDNESDAY 26th | 13:00 - 13:30
Add to calendar2021-05-26 13:00 2021-05-26 13:30 Europe/Madrid AUTHORS WITH POSTERS (Lunchtime grouping) AUTHORS WITH POSTERS (Lunchtime grouping)EAPCCT 2021
ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT
WEDNESDAY 26th | 13:30 - 15:30
Moderators: Michael Eddleston, United Kingdom and Knut Erik Hovda, NorwayAdd to calendar2021-05-26 13:30 2021-05-26 15:30 Europe/Madrid ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT Moderators: Michael Eddleston, United Kingdom and Knut Erik Hovda, NorwayEAPCCT 2021
13:30-13:50 | Alcohol as a co-ingestant with stimulant recreational drugs and energy drinks Chris Yates, SAMU 061 Balears, Palma de Mallorca, Spain |
13:50-14:10 | Alcohol as a co-ingestant with benzodiazepines and/or other CNS depressants Tobias Zellner, TUM School of Medicine, Technical University of Munich, Munich, Germany |
14:10-14:30 | Interactions between alcohol and organophosphate insecticide poisoning Michael Eddleston, University of Edinburgh, UK |
14:30-14:50 | Poisonings where ethanol may be acutely protective – paracetamol Kim Dalhoff, Bispebjerg University Hospital, Copenhagen, Denmark |
14:50-15:10 | Poisoning where ethanol is protective - the toxic alcohols Ken McMartin, Louisiana State University Health Sciences Center, Shreveport, USA |
15:10-15:20 | Fomepizole during continuous renal replacement therapy, an observational study Yvonne Lao, Oslo, Norway (2021- Abstract 297) |
15:20-15:30 | Questions & Answers to the Alcohol as a Co-ingestant in the Poisoned Patient speakers |
At the end of this session the audience should be able to:
- Discuss mechanistically how alcohol complicates management of stimulant drug ingestion and provide specific examples.
- Describe the effect of ethanol when co-ingested with CNS-depressants in regard to symptoms, clinical management and outcome.
- Explain how blood alcohol concentration interacts with insecticide dosing to worsen outcome in OP insecticide poisoning.
- Listing clinically relevant studies of the effect(s) of alcohol on paracetamol toxicity, explain the possible protective mechanism of alcohol and debate the pros and cons of alcoholuse in the treatment of paracetamol poisoning.
- Describe how ethanol can be used to treat methanol and ethylene glycol poisonings .
Rest break and AUTHORS WITH POSTERS (Afternoon grouping)
WEDNESDAY 26th | 15:45 - 16:15
Add to calendar2021-05-26 15:45 2021-05-26 16:15 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Afternoon grouping) Rest break and AUTHORS WITH POSTERS (Afternoon grouping)EAPCCT 2021
FELLOWS LECTURE
WEDNESDAY 26th | 16:15-17:15
Moderators: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyAdd to calendar2021-05-26 16:15 2021-05-26 17:15 Europe/Madrid FELLOWS LECTURE Moderators: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyEAPCCT 2021
16:15-16:20 | Introduction |
16:20-17:15 | Inaugural Fellows Lecture: “Vaping Induced Lung Injury” David Christiani, Harvard University , Boston, USA |
At the end of this session the audience should be able to:
- Understand the exposures contained in current electronic vaping products in common use.
- Understand the Acura effects of vaping aerosol exposure on the henna lung.
- Understand the clinical syndromes associated with vaping.
- Understand management and prevention interventions in EVALI. 7
UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP
WEDNESDAY 26th | 15:30 - 15:45
Moderators: Alex Campbell, United Kingdom and Lotte Hoegberg, DenmarkAdd to calendar2021-05-26 15:30 2021-05-26 15:45 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Moderators: Alex Campbell, United Kingdom and Lotte Hoegberg, Denmark EAPCCT 2021
15:30-15:45 | STATUS: QT prolongation in poisoning, Activated Charcoal, Paracetamol Sophie Gosselin, CISSS de la Montérégie-Centre, Montreal, Canada |
END OF DAY 1
WEDNESDAY 26th | 17:15 - 17:30
Hosts: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyAdd to calendar2021-05-26 17:15 2021-05-26 17:30 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Hosts: Allister Vale, United Kingdom and Hugo Kupferschmidt, GermanyEAPCCT 2021
WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM
THURSDAY 27th | 08:45 - 09:00
Host: Alex Campbell, United KingdomAdd to calendar2021-05-27 08:45 2021-05-27 09:00 Europe/Madrid WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM Host: Alex Campbell, United Kingdom EAPCCT 2021
APAMT SYMPOSIUM: TOXICOVIGILANCE DURING COVID-19 IN THE ASIAN-PACIFIC REGION
THURSDAY 27th | 09:00 - 10:30
Moderators: Nick Buckley, Australia and David Wood, United KingdomAdd to calendar2021-05-27 09:00 2021-05-27 10:30 Europe/Madrid APAMT SYMPOSIUM: TOXICOVIGILANCE DURING COVID-19 IN ASIA-PACIFIC Moderators: Nick Buckley, Australia and David Wood, United KingdomEAPCCT 2021
09:00-09:05 | Introduction to the session Nick Buckley, Australia and David Wood, United Kingdom |
09:05-09:25 | Covid-19, disinfection and methanol poisoning: A report from Iran Hossein Hassanian-Moghaddam, Iran |
09:25-09:45 | Toxic disasters in India during Covid-19 pandemic Ashish Bhalla, India |
09:45-10:00 | Caveat Emptor: Covid-19 and impacts on surPRISE illicit drug poisonings in Australia Thanjira Jiranantakan ,Australia |
10:00-10:20 | Ketamine Adulteration in Thailand: the issue of supply and demand during Covid-19 Summon Chomchai, Thailand |
10:20-10:30 | Questions & Answers to the Session |
At the end of this session the audience should be able to:
- Learn about significant toxic exposures during COVID-19 pandemic in Asia -Pacific area.
- Understand key steps of toxicovigilance taken in an Asian Pacific context
- Apply lessons learned about the signal identification, data gathering, risk assessment and responses measures to their local context.
Rest break and AUTHORS WITH POSTERS (Morning grouping)
THURSDAY 27th | 10:30-11:00
Add to calendar2021-05-27 10:30 2021-05-27 11:00 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Morning grouping) Rest break and AUTHORS WITH POSTERS (Morning grouping)EAPCCT 2021
ORAL PLATFORM AND SHORT ORAL PRESENTATIONS
THURSDAY 27th | 11:00 - 11:35
Moderators: Gabija Laubner, Lithuania and Katrin Faber, SwitzerlandAdd to calendar2021-05-27 11:00 2021-05-27 11:35 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Moderators: Gabija Laubner, Lituania and Katrin Faber, SwitzerlandEAPCCT 2021
11:00-11:20 | Unintentional exposure to immediate-release Tramadol in ≤6-year old children: A nationwide French Poisons Control Centre study Dominique Vodovar, Paris, France (2021- Abstract 298) |
11:20-11:30 | Enquiries to the National Poisons Information Centre, Ireland concerning patients Myles Monaghan, Dublin, Ireland (2021- Abstract 299) |
11:30-11:35 | Questions & Answers to the Alcohol as a Co-ingestant in the Poisoned Patient speakers |
FELLOWS MEETING
THURSDAY 27th | 11:40-12:30
Hosts: Allister Vale, Hugo Kupferschmidt, Ian WhyteAdd to calendar2021-05-27 11:40 2021-05-27 12:30 Europe/Madrid FELLOWS MEETING Hosts: Allister Vale, Hugo Kupferschmidt, Ian WhyteEAPCCT 2021
AUTHORS WITH POSTERS (Lunchtime grouping)
THURSDAY 27th | 12:30-13:00
Hosts: Allister Vale, Hugo Kupferschmidt, Ian WhyteAdd to calendar2021-05-27 12:30 2021-05-27 13:00 Europe/Madrid AUTHORS WITH POSTERS (Lunchtime grouping) AUTHORS WITH POSTERS (Lunchtime grouping)EAPCCT 2021
YOUNG INVESTIGATORS AWARD
THURDSDAY 27th | 13:00-14:00
Moderators: Mark Zammit, Malta and Piotr Kabata, PoloniaAdd to calendar2021-05-27 13:00 2021-05-27 14:00 Europe/Madrid YOUNG INVESTIGATORS AWARD Moderators: Mark Zammit, Malta and Piotr Kabata, Polonia)EAPCCT 2021
13:00-13:05 | Welcoming to the Young investigators award |
13:05-13:20 | A 2 bag intravenous acetylcysteine regimen results in fewer treatment delays in the management of paracetamol overdose Anselm Wong, Australia (YIA 2021- Abstract 300) |
13:20-13:35 | Decision support for toxin prediction using artificial intelligence Tobias Zellner, Munich Germany (YIA 2021 -Abstract 301) |
13:35-13:50 | "Flu" the Looking-Glass: observational poison center study evaluating adverse events secondary to flumazenil administration over time Varun Vohra, USA (YIA 2021 -Abstract 302) |
13:50-14:00 | Collection of votes and Announcement of the winner of YIA |
COVID-19 SYMPOSIUM
THURDSDAY 27th | 14:00-15:30
Moderators: Evangelia Liakoni, Switzerland and Erik Lindeman, SwedenAdd to calendar2021-05-27 14:00 2021-05-27 15:30 Europe/Madrid COVID-19 SYMPOSIUM Moderators: Evangelia Liakoni, Switzerland and Erik Lindeman, SwedenEAPCCT 2021
14:00-14:20 | Impact of COVID on poisons centres - a European perspective Davide Lonati, Pavia Poison Control Centre, Pavia, Italy |
14:20-14:40 | Impact of COVID-19 on poisons centers - a US perspective Diane Calello, Rutgers New Jersey Medical School, USA |
14:40-15:00 | The impact of the first wave of COVID-19 on Poisons Centre (PC) activities in 4 European countries: a pilot study Laura Hondebrink, Utrecht, Netherlands (2021- Abstract 303) |
15:00-15:10 | A networked approach to a SARS-COV-2 information hotline in the state of Florida - design, implementation and lessons learned Alfred Aleguas, Tampa, Florida, USA (2021 -Abstract 304) |
15:10-15:20 | Virtual education and networking during COVID: the ACMT COVID-19 Webinar series Paul Wax, ACMT, Phoenix, USA |
15:20-15:30 | Questions & Answers to the Oral Platform Session speakers |
At the end of this session the audience should be able to:
- Describe the effect of pandemic waves on Europe Health System and how the EAPCCT working-group is investigating the influence of the COVID-19 pandemic on the work of European Poison Control Centres (PCCs).
- Describe the process of expanding the role of a regional poison center to provide a 24/7 public health hotline in response to the COVID-19 pandemic, as an information service as well as a critical component of surveillance and response.
- Describe the opportunities for virtual toxicology education and networking during a pandemic.
Rest break and AUTHORS WITH POSTERS (Afternoon grouping)
THURSDAY 27th | 15:30-16:00
Add to calendar2021-05-27 15:30 2021-05-27 16:00 Europe/Madrid Rest break and AUTHORS WITH POSTERS (Afternoon grouping) Rest break and AUTHORS WITH POSTERS (Afternoon grouping)EAPCCT 2021
COVID-19 SYMPOSIUM
THURSDAY 27th | 16:00-17:40
Moderators: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomAdd to calendar2021-05-27 16:00 2021-05-27 17:40 Europe/Madrid COVID-19 SYMPOSIUM Moderators: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomEAPCCT 2021
16:00-16:20 | Toxicity of drugs and "other treatments" - Toxicity of therapeutic drugs used for COVID: an overview of the drugs used to treat COVID Caroline Samer, Geneva University Hospitals, Switzerland |
16:20-16:40 | Toxicity of drugs and "other treatments" - Use of non-recommended toxic treatments (toxic alcohols/cleaning products etc. Craig Smollin, University of California, San Francisco, USA |
16:40-17:00 | Impact of COVID-19 on recreational drugs in Europe - an overview from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Isabelle Giraudon, EMCDDA, Lisbon, Portugal |
17:00-17:20 | Intentional poisoning cases reported to the National Poisons Information Centre during the initial lockdown phase of COVID-19 Public Health restrictions Nicola Cassidy, Dublin, Ireland (2021 Abstract 305) |
17:20-17:30 | Recreational drug toxicity Emergency Department presentations during the initial months of the COVID-19 pandemic Juan Ortega Pérez, Palma de Mallorca, Spain (2021- Abstract 306) |
17:30-17:40 | Questions & Answers to the Oral Platform Session speakers |
At the end of this session the audience should be able to:
- List the repurposed and new drugs used in the context of COVID19 and outline the available clinical data regarding their efficacy and safety for COVID19 prophylaxis and treatment
- Describe the mechanism of toxicity and treatment of patients exposed to sodium chlorite.
- To learn about the impact of COVID-19 on recreational drugs in Europe (including on market, use, harm and treatment) based on a 'Trendspotter analysis' of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
END OF DAY 2
THURSDAY 27th | 17:40 - 17:50
Hosts: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomAdd to calendar2021-05-27 17:40 2021-05-26 17:50 Europe/Madrid UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP Hosts: Ana Ferrer Dufol, Spain and Paul Dargan, United KingdomEAPCCT 2021
DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT
FRIDAY 28th | 09:00 - 10:30
Moderators: Davide Lonati, Italy and Anselm Wong, AustraliaAdd to calendar2021-05-28 09:00 2021-05-28 10:30 Europe/Madrid DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT Moderators: Davide Lonati, Italy and Anselm Wong, Australia EAPCCT 2021
09:00-09:20 | The impact of new drug formulations on the assessment of the poisoned patient Andis Graudins, Monash Health, Melbourne, Australia |
09:20-09:35 | The pharmacology of pharmacobezoars Lotte Hoegberg, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark |
09:35-09:55 | Management of pharmacobezoars Soeren Boegevig, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark |
09:55-10:10 | Misuse of prescriptions medicines by routes other than the intended route of use David Wood, Guy's and St Thomas' NHS Foundation Trust, London, UK |
10:20-10:30 | Questions & Answers to the Session |
At the end of this session the audience should be able to:
- Explain the pharmacokinetic and pharmacodynamic features of poisoning with various newer drug formulations that can influence the risk assessment and initial management of the poisoned patient.
- Identify known physicochemical properties of pharmaceutical preparations prone to cause pharmacobezoar formation - the formation and degradation.
- Describe ways to identify the formation of pharmacobezoars and possible treatment modalities in the poisoned patient where their formation is suspected or identified.
- Understand the frequency of and methods by which prescription medicines can be used by routes other than the intended licenced route(s) of use.
Rest break and Authors with posters (Morning grouping)
FRIDAY 28th | 10:30-11:00
Add to calendar2021-05-28 10:30 2021-05-28 11:00 Europe/Madrid Rest break and Authors with posters (Morning grouping) Rest break and Authors with posters (Morning grouping) EAPCCT 2021
LOUIS ROCHE LECTURE
FRIDAY 28th | 11:00 - 12:00
Add to calendar2021-05-28 11:00 2021-05-28 12:00 Europe/Madrid LOUIS ROCHE LECTURE LOUIS ROCHE LECTUREEAPCCT 2021
11:00-11:15 | Introduction and presentation of the Louis Roche Lecturer Horst Thiermann, EAPCCT President |
11:15-12:00 | Improving the evaluation, management and outcome of cardiotoxicant-poisoned patients - still a challenge for clinical toxicologists Bruno Mégarbane, Paris-Diderot University, France |
At the end of this session the audience should be able to:
- understand the contribution of the proposed different therapies in cardiotoxicant poisonings
Authors with posters (Lunchtime grouping)
FRIDAY 28th | 12:00 - 12:30
Add to calendar2021-05-28 12:00 2021-05-28 12:30 Europe/Madrid Authors with posters (Lunchtime grouping) Authors with posters (Lunchtime grouping)EAPCCT 2021
GENERAL ASSEMBLY
FRIDAY 28th | 13:00 - 14:15
Hosts: Horst Thiermann (EAPCCT President), Davide Lonati (EAPCCT General Secretary), Sergej Zakharov and Bruno Mégarbane (EAPCCT Treasurers)Add to calendar2021-05-28 13:00 2021-05-28 14:15 Europe/Madrid GENERAL ASSEMBLY Hosts: Horst Thiermann (EAPCCT President), Davide Lonati (EAPCCT General Secretary), Sergej Zakharov and Bruno Mégarbane (EAPCCT Treasurers)EAPCCT 2021
TOXICOLOGY 2.0 SYMPOSIUM
FRIDAY 28th | 14:15 - 16:45
Moderators: Chris Yates, Spain and Mark Zammit, MaltaAdd to calendar2021-05-28 14:15 2021-05-28 16:45 Europe/Madrid TOXICOLOGY 2.0 SYMPOSIUM Moderators: Chris Yates, Spain and Mark Zammit, Malta EAPCCT 2021
14:15-14:30 | Games for dissemination of poison prevention education to the public Yu-Hao Cheng, Taiwan National Poison Control Center, Taipei, Taiwan |
14:30-14:45 | Artificial intelligence in medicine and toxicology: current trends and outlook Matjaž Kukar, University of Ljubljana, Slovenia |
14:45-14:55 | Using Artificial Intelligence to understand recreational drug usage and toxicity from internet forums Michael Chary (2020- Abstract 098) |
14:55-15:10 | The role of data from drug user forums in determining recreational drug and NPS toxicity Sage Wiener, SUNY Downstate Health Sciences University, New York, USA |
15:10-15:25 | Google metrics and twitter to monitor recreational drugs and NPS trends Jean Marie Perrone, University of Pennsylvania , Philadelphia, USA |
15:25-15:35 | The geospatial and linguistic dynamics of conversations on Twitter about vaping Michael Chary (2020 -Abstract 099) |
15:35-15:50 | Robotic wastewater analysis to understand community consumption of opioids, cocaine, NPS and methamphetamines Claire Duvallet, Biobot Analytics, Boston, USA |
15:50-16:05 | Web monitoring tools to monitor trends in prescription medicine misuse Rick Dart, Denver Health and Hospital Authority, Denver, USA |
16:05-16:20 | Ingestible Electronics and Robotic Systems to measure medication adherence and drug use events Peter Chai, Brigham and Women's Hospital, Boston, USA |
16:20-16:35 | Telemedicine as an assessment tool in chemical weapon attacks, experience in Syria with global implications Tim Erickson, Brigham Health / Harvard Medical School, Boston, USA |
16:35-16:45 | Questions & Answers to the Toxicology 2.0 speakers |
At the end of this session the audience should be able to:
- Identify important poisoning trends.
- State the features of poisoning events in different age groups.
- Describe the importance and challenges of poison prevention education.
- List two effective strategies for delivering poison prevention knowledge to children.
- Describe various modern artificial intelligence techniques, applicable in different scenarios and types of data (tabular data, images, text), as well as determine and decide which particular problems are suitable for application of AI techniques.
- Explain the role of online drug information forums in both reflecting and driving patterns of drug use, and their utility and limitations in studying these patterns.
- Describe tools in Google and Twitter that can help characterize novel psychoactive substance trends.
- Explain the basic concepts behind using wastewater epidemiology to measure populationlevel exposure and consumption of opioids, cocaine, NPS and methamphetamines and describe results from a pilot study applying wastewater epidemiology to map opioid consumption in a US municipality
- Understand the appropriate use of data derived from various types of social media.
- Understand the current state of art in ingestible electronics and the principles of biosensing in drug testing.
- Describe current use of telemedicine and other emerging technologies in the setting of chemical weapon attacks.
Rest break and Authors with posters (Afternoon grouping)
FRIDAY 28th | 16:45-17:15
Add to calendar2021-05-28 16:45 2021-05-28 17:15 Europe/Madrid Rest break and Authors with posters (Afternoon grouping) Rest break and Authors with posters (Afternoon grouping)EAPCCT 2021
END OF DAY 3, END OF EAPCCT 2021 VIRTUAL CONFERENCE
FRIDAY 28th | 17:50
Moderators: Horst Thiermann, Lotte Hoegberg Copenhagen, DenmarkAdd to calendar2021-05-28 17:50 2021-05-28 18:00 Europe/Madrid END OF DAY 3, END OF EAPCCT 2021 VIRTUAL CONFERENCE Moderators: Horst Thiermann, Lotte Hoegberg Copenhagen, DenmarkEEAPCCT 2021
ORAL PLATFORM AND SHORT ORAL PRESENTATIONS
FRIDAY 28th | 17:15 - 17:50
Moderators: Thiermann, Munich, Germany and Lotte Hoegberg, Copenhagen, DenmarkAdd to calendar2021-05-28 17:15 2021-05-28 17:50 Europe/Madrid ORAL PLATFORM AND SHORT ORAL PRESENTATIONS Moderators: Thiermann, Munich, Germany and Lotte Hoegberg, Copenhagen, Denmark EAPCCT 2021
17:15-17:25 | Foodborne botulism: a large outbreak in Sicily Azzurra Schicchi, Pavia, Italy (2021 Abstract 307) |
17:25-17:45 | Shiitake Dermatitis: a French nationwide study 2014-2019 David Boels, Nantes, France (2021- Abstract 308) |
17:45-17:50 | Questions & Answers to the Oral platform and Short Oral Presentation speakers |
WELCOME DAY 3 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM
FRIDAY 28th | 08:45 - 09:00
Host: Alex Campbell, United KingdomAdd to calendar2021-05-28 08:45 2021-05-28 09:00 Europe/Madrid WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM Host: Alex Campbell, United Kingdom EAPCCT 2021
REST BREAK / AUTHORS WITH POSTERS (MORNING GROUPING)
- Morning Posters - Room 01
116 Massive gamma-hydroxybutyric acid overdose resulting in severe metabolic acidosis requiring continuous venovenous haemofiltration
Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology and Emergency Department, Austin Health, Victoria, Australia.
Drugs of abuse and NPS poisoning
138 Just “https://eapcct2021.com/administrator/index.php#wf-editor-sourcenanging” around: case series of neurological sequelae from chronic nitrous oxide abuse
Angela L Chiew, Clinical Toxicology Unit, Prince of Wales Hospital, Sydney, Australia.
Drugs of abuse and NPS poisoning
197 Analytically-confirmed exposure to new psychoactive substances in patients with severe clinical toxicity in the UK, 2015-2018: a report from the IONA study
Simon H Thomas, Narional Poisons Information Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
Drugs of abuse and NPS poisoning
198 Increasing abuse and addiction to nitrous oxide (N2O): still a legal high in Denmark
Lotte CG Hoegberg, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Drugs of abuse and NPS poisoning
309 Severe cardiac and neurological toxic effects due to synthetic cannabinoid cumyl-pegaclone (SGT-151) alone: a case report
Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
Drugs of abuse and NPS poisoning
310 Beta-hydroxybutyrate closed the gap in a sober patient with high anion gap metabolic acidosis: a case report
Marian Piqueur, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
Drugs of abuse and NPS poisoning - Morning Posters - Room 02
117 Hyperemesis and acute kidney injury following a “rebirth” ceremony with kambô and iboga in the Netherlands
Marian Piqueur, Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
Drugs of abuse and NPS poisoning
126 Clinical effects following the use of freely available herbal drugs: the toxicity of “Happy Caps”
Antoinette JHP Riel, Dutch Poisons Information Center(DPIC), Univesity Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Drugs of abuse and NPS poisoning
131 Recreational nitrous oxide use rises dramatically after change in EU legislation
Antoinette JHP Van Riel, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht Univeristy, Utrecht, Netherlands.
Drugs of abuse and NPS poisoning
136 Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
137 Self-discharge during treatment for acute recreational drug toxicity: an analysis of four-years of Euro-DEN Plus presentations
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
150 Treatment with naloxone and follow up after opioid overdose outside of hospital: observational data 2014-2018 in Oslo, Norway
Arne K Skulberg, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway; Pre-hospital Division, Air Ambulance Department, Oslo University Hospital, Oslo, Norway ; The Norwegian Air Ambulance Foundation, Oslo, Norwa, Trondheim, Norway.
Drugs of abuse and NPS poisoning
158 Change of quality of life in prescription opioid patients after rapid opioid detoxification
Gabija Laubner, Republican Vilnius University Hospital, Centre of Toxicology; Vilnius University Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Drugs of abuse and NPS poisoning
160 First identification of synthetic cannabinoid 5F-MDMB-PICA in Italy
Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Drugs of abuse and NPS poisoning
313 Poisoning by central stimulant drugs in Oslo, Norway
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
314 Acute poisoning from concurrent use of opioids and amphetamine
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
315 Acute recreational drug toxicity among young patients
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
316 Acute poisonings involving cannabis in Oslo, Norway
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
317 Psychosis associated with acute recreational drug toxicity
Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning - Morning Posters - Room 03
007 The severity and mortality prediction of calcium-channel blocker poisoning in the intensive care unit
Chun Kuei Chen, Emergency department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
Pharmaceutical Poisoning
201 Comparison of the Australian and New Zealand Referral Criteria versus the King’s College Criteria to predict mortality or liver transplant in paracetamol overdose
Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Victoria, Australia.
Pharmaceutical Poisoning
241 Angiotensin axis antagonists increase the severity of dihydropyridine poisoning
Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
Pharmaceutical Poisoning
242 A case series of flecainide poisoning
Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
Pharmaceutical Poisoning
243 Effect of serum alkalinisation on QRS narrowing in tricyclic antidepressant poisoning
Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
Pharmaceutical Poisoning
244 Optimal way to achieve serum alkalinisation in tricyclic antidepressant overdose
Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hosptial, Sydney, Australia.
Pharmaceutical Poisoning
246 An uncommon cause of high-anion gap metabolic acidosis after repeated supratherapeutic paracetamol ingestion
Hwee Min D Lee, Emergency, Monash Health, Melbourne, Australia.
Pharmaceutical Poisoning
262 Lurasidone mono-ingestion overdoses: a case series with minimal toxicity
Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
Pharmaceutical Poisoning
331 A 1-year prospective analysis of propranolol exposures reported to the UK National Poisons Information Service (NPIS)
Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
Pharmaceutical Poisoning
332 Intravenous pentobarbital overdose treated with supportive care and multidose activated charcoal
Rachel WC Ng, Clinical Pharmacology and Toxicology, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
Pharmaceutical Poisoning
333 The impact of codeine upscheduling on prescriptions, overdoses, Emergency Department presentations and mortality in Victoria, Australia
Anselm Wong, Victorian Poisons Information Centre and Austin Toxicology Unit, Austin Health, Victoria, Australia.
Pharmaceutical Poisoning - Morning Posters - Room 04
196 Is fentanyl responsible for more severe neuro-respiratory depression than morphine? A rat in vivo investigation
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Mechanisms of Toxicity and Basic Research
231 Sarolaner-poisoning in an infant: a case report
Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
Pharmaceutical Poisoning
252 Acute kidney failure due to acetaminophen overdose: a case report
Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
Pharmaceutical Poisoning
253 Venlafaxine-associated hypoglycemia: frequency and correlation with symptom severity
Elias Bekka, Department of Clinical Toxicology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Pharmaceutical Poisoning
254 Hydroxyzine poisoning in the intensive care unit: predictive factors of cardiovascular complications and toxicokinetics
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
255 Lamotrigine poisoning in the ICU: a case series with evaluation of the toxicocokinetics and the predictive value of the plasma concentration on admission
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
256 Rispiridone poisoning in the intensive care unit: evaluation of the poisoning severity on admission
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
257 Nicardipine poisoning in the intensive care unit: management, outcome and toxicokinetics
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
258 Poisonings involving angiotensin-converting enzyme inhibitors in the intensive care unit: a case series
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
259 Salicylate poisoning admitted to the intensive care unit: features and toxicokinetics
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
260 Antidepressant drug poisonings and the risk of thromboembolic complications: a case series from an intensive care unit
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Pharmaceutical Poisoning
263 Combined beta-blocker and beta-agonist drugs overdose: an unusual balance
Andrea Giampreti, Bergamo Poison Control Center, Papa Giovanni XXIII Hospital, BERGAMO, Italy.
Pharmaceutical Poisoning
264 Characteristics of use and outcome of naloxone administration to non-intensive care and non-surgical hospitalized adult patients: a pilot study
Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
Pharmaceutical Poisoning
266 Medication errors in nursing homes and other residential institutions with full-time staff attendance: a Danish Poisons Information Centre quality project
Karen R Eriksen, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Pharmaceutical Poisoning
268 Crisis averted? Olanzapine as an antidote for serotonin toxicity: a case report
Erik Lindeman, Swedish Poisons Informatiom Center, Stockholm, Sweden.
Pharmaceutical Poisoning
269 Non-cardiogenic pulmonary edema in amlodipine poisoning: the lesser evil?
Erik Lindeman, Swedish Poisons Information Center, Stockholm, Sweden.
Pharmaceutical Poisoning
271 Pharmacobezoar and gastric perforation in severe quetiapine intoxication: a case report
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Pharmaceutical Poisoning
273 Intoxication with colchicine: a retrospective study
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Pharmaceutical Poisoning
334 Intravenous iron overdose: don’t trust the blood levels
Ann-Charlott Svanhagen, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
Pharmaceutical Poisoning - Morning Posters - Room 05
011 Hydrofluoric acid exposure: a five-year review of enquiries made to the UK National Poisons Information Service (NPIS)
Michael J Beech, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
Epidemiology of poisoning
012 Enquiries to the National Poisons Information Centre in Ireland from ambulance control, emergency medical dispatchers and paramedics attending poisoning incidents from 2010-2018
Edel Duggan, National Poisons Information Centre, Beaumont Hospital, Dublin, Ireland.
Epidemiology of poisoning
014 109 toxicological inquiries for one patient
Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
Epidemiology of poisoning
019 Eye injuries: case reports to the BfR from 2004 to 2018
Kathrin Begemann, Department Exposure, Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Epidemiology of poisoning
020 A worrying trend: Poisonings with pharmaceuticals in young girls in Norway
Merethe Midtervoll, Norwegian Poison Information Centre, National Institute of Public Health, Oslo, Norway.
Epidemiology of poisoning
021 Study on e-liquids: risk of exposure and effectiveness of regulation by Tobacco Products Directive 2
Nina Glaser, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Epidemiology of poisoning
025 Mortality and patient characteristics in paracetamol overdosing: a retrospective study
Soeren Boegevig, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Epidemiology of poisoning
106 Assessment of advice given by the Danish Poisons Information Centre concerning medication errors in nursing homes and institutions
Soeren Boegevig, Department of Clinical Pharmacology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Epidemiology of poisoning
108 Utilization of the Danish Poisons Information Centre: a nationwide registry study
Tonny S Petersen, Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark.
Miscellaneous - Morning Posters - Room 06
077 Beauty can occasionally be toxic: local irritation from a houseplant
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Plant and Mushroom Poisoning
087 Kombucha tea: a potential hepatotoxic agent
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Plant and Mushroom Poisoning
348 Veratrum Aqua poisonings resulting from its misuse: a case series from Moscow, Russia
Elizaveta V Melnik, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
Plant and Mushroom Poisoning - Morning Posters - Room 07
046 Unanticipated sources of methanol poisoning: report of two cases
Jones CM Chan, Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
Household Products Poisoning
049 Laundry pod exposure in children: evaluation of 17 years’ of cases in a tertiary care hospital in Italy
Marcello Montibeller, Department of Emergency. Regional Paediatric Control Center., Bambino Gesù Children's Hospital, Rome, Italy.
Household Products Poisoning
351 Protective effects of hypercalcaemia in the setting of severe hypermagnesaemia
David Emmerig, Western Sydney Local Health District Toxicology Service, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
Household Products Poisoning
352 Caustic exposures attending the Emergency Department: results of the Spanish Toxic Surveillance System (STSS) 2010-2019
Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
Household Products Poisoning - Morning Posters - Room 08
036 Assessment of the effectiveness of gastric lavage in organophosphorus poisoning by quantifying pesticide in lavage fluid
Indira Madhavan, General Medicine, Associate Proferssor, Thrissur, India.
Pesticide Poisoning
042 Human exposures to pesticides: results of a subproject of the German pilot study PiMont
Esther Feistkorn, German Federal Institute for Risk Assessment, Department Exposure, Unit Exposure Assessment of Hazardous Products, Berlin, Germany.
Pesticide Poisoning
358 Hepatorenal dysfunction following fipronil ingestion
Indira Madhavan, Government Medical College, Thrissur, India.
Pesticide Poisoning
359 Malathion poisoning causing prolonged cholinergic crisis and refractory hypotension requiring high-dose atropine treatment
Kit Rowe, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
(only available on May 27th)
Pesticide Poisoning - Morning Posters - Room 09
002 A watchful foretaste of Article 45 Annex VIII: things you will wish you knew before
Geert Verstegen, Belgian Poison Centre, Brussels, Belgium.
Miscellaneous
003 Current experience of the Belgian Poison Centre with the new product notification requirements implementing article 45
Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
Miscellaneous
179 Human skin explants ex vivo study: lesions caused by topical exposure to 25% tetramethylammonium hydroxide (TMAH)
Alan H Hall, Medical Toxicology, Toxicology Consulting and Medical Translating Services, Azle, Texas, United States.
Miscellaneous
190 Risk assessment and lessons learned: a collaboration between Public Health and a National Poisons Information Centre
Edel Duggan, National Poisons Information Centre, Dublin, Ireland.
Miscellaneous
204 Bedside formate analysis in methanol poisoned patients: a pilot study
Knut Erik Hovda, The National CBRNE Centre of Medicine, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
Analytical and Forensic Toxicology - including bedside testing
205 Bedside quantitative electroencephalographic monitoring using the Patient State Index correlates poorly with Glasgow Coma Score in acutely poisoned patients
Shaun L Greene, Victoria Poisons Information Centre, Austin health, Melbourne, Australia.
Pharmaceutical Poisoning
207 A one-year retrospective study of caustic injury in adults admitted to a toxicology department
Julia V Radenkova-Saeva, Clinic of Toxicology, UMHATEM "N.I.Pirogov", Sofia, Bulgaria.
Caustic ingestion
210 False positive result on colorimetric methanol screening test: report of two cases with hyperglycaemia
Jones CM Chan, Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
Analytical and Forensic Toxicology - including bedside testing - Morning Posters - Room 10
057 Alcohol "abuse" among children younger 5 years
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Paediatric Poisoning
060 Overrepresentation of flavoured, orodispersible tablets in paediatric paracetamol overdoses
Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
Paediatric Poisoning
061 Drug-induced liver injury induced by nicotinamide
Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
Paediatric Poisoning
064 Pediatric and adolescent self-poisoning: a 3-year case series
Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Paediatric Poisoning
202 Three years of experience implementing a chemical submission protocol at an Emergency Department
Juan Ortega Pérez, Emergengy Department Hospital Universitari Son Espases, Attending Physician, Palma de Mallorca, Spain.
Miscellaneous
367 The importance of free digoxin serum concentrations: case report of an infant treated for digoxin poisoning
Marco Marano, Pediatric Intensive Care Unit; Pediatric Poison Control Center, Children's Hospital Bambino Gesù, Rome, Italy.
Paediatric Poisoning
368 Fentanyl transdermal patch mistaken for wound patch: two pediatric case reports
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Paediatric Poisoning
369 Bottles and messages revisited: circumstances of poisonings among infants under 1 year old in Estonia
Ruth Kastanje, Poisonings Information Centre, Estonian Health Board, Tallinn, Estonia.
Paediatric Poisoning
370 Alcohol abuse among teenagers during the vacation period: description and pattern differences by gender
Juan Ortega Pérez, Adult emergency department. Toxicology Unit, Attending physician, Palma de Mallorca, Spain.
Paediatric Poisoning
372 Paediatric paracetamol overdose: reducing side-effects with the SNAP 12 hour N-acetylcysteine regime
David G Cairney, Acute Receiving Unit, Royal Hospital for Sick Children, Edinburgh, United Kingdom.
Paediatric Poisoning - Morning Posters - Room 11
195 Antidote treatment in viper envenomation in Italy: a comparison of 4 antivenoms during a 6 year study
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Toxinology (bites, stings, antivenom etc)
278 The changing pattern of treatment for latrodectism over time in a toxicology unit: red-back spider antivenom or standard analgesic therapy: nothing to RAVE about
Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
Toxinology (bites, stings, antivenom etc)
280 A serious viper bite in a pregnancy
Francesco Gambassi, Toxicology Unit and Poison Control Center, Firenze, Italy.
Toxinology (bites, stings, antivenom etc)
281 Spider bites in France: a retrospective study using the French Poison Control Centers Network from 2007 to 2017
Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, Centre antipoison et Toxicovigilance Grand Ouest, Angers, France.
Toxinology (bites, stings, antivenom etc)
283 Recurrent thrombocytopenia after Italian viper bite: a case report
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy, Pavia, Italy.
Toxinology (bites, stings, antivenom etc)
377 Hyperbaric oxygen therapy in Loxoscelism skin necrosis: a case report
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Toxinology (bites, stings, antivenom etc)
378 Exotic venomous snakebites in Switzerland reported to the National Poisons Information Centre over 22 years
Joan Fuchs, Tox Info Suisse, University of Zurich, Zurich, Switzerland.
Toxinology (bites, stings, antivenom etc)
379 Far from home: compartmental syndrome after envenomation by Crotalus atrox in metropolitan France
Gaël Le Roux, Poison Control Center and Toxicovigilance, Angers, France.
Toxinology (bites, stings, antivenom etc)
380 Human exposure to larvae of processionary moths in France: study of symptomatic cases registered by the French Poison Control Centres between 2012 and 2019
Sandra Sinno-Tellier, Health Alerts and Vigilance Department, French Agency for Food, environmental and Occupational Health & Safety, Maisons-Alfort, France.
Toxinology (bites, stings, antivenom etc)
AUTHORS WITH POSTERS (LUNCHTIME GROUPING)
- Lunchtime Posters - Room 01
119 3,4-Methylenedioxy-α-pyrrolidinohexiophenone (MDPHP): four severe confirmed intoxicationsn
Dieter Müller, Clinical Toxicology Laboratory, GIZ-Nord Poisons Centre, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
Drugs of abuse and NPS poisoning
143 Methadone poisonings admitted to the ICU: investigation of the predictive value of plasma methadone concentration and the required naloxone dose regimen
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Drugs of abuse and NPS poisoning
147 Severe acidosis and prolonged coma after a massive overdose of gamma-hydroxybutyrate (GHB)
Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
Drugs of abuse and NPS poisoning
155 The development of poisonings with illegal substances: data from the Danish Poisons Information Centre (DPIC)
Dorte F Palmqvist, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Drugs of abuse and NPS poisoning
318 E-liquid sold as CBD e-liquid containing XRL-11: 4 cases reported. A warning signal to health authorities and e-cigarettes users
Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
Drugs of abuse and NPS poisoning
319 Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
Drugs of abuse and NPS poisoning
320 Swedes like their O-juice from Florida and their E-juice from California
Sonny Larsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
Drugs of abuse and NPS poisoning
321 Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Drugs of abuse and NPS poisoning
322 Recreational, inhalational misuse of hyoscine butylbromide (Buscopan®) tablets as reported to the UK National Poisons Information Service
Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
Drugs of abuse and NPS poisoning
323 A case of crack-lung-like syndrome due to new synthetic opioid consumption with analytical confirmation
Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre – Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Drugs of abuse and NPS poisoning - Lunchtime Posters - Room 02
124 In-patient prescription opioid detoxification: peculiarities of consumption and treatment outcomes
Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
Drugs of abuse and NPS poisoning
125 In-patient prescription opioid detoxification: gender differences and harmful habits
Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
Drugs of abuse and NPS poisoning
132 Analysis of drugs in blood and urine samples from suspected spiked drink victims
Odd Martin Vallersnes, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Drugs of abuse and NPS poisoning
142 Transient delayed brain edema after consumption of synthetic cathinones
Sabrina Schmoll, Department for clinical toxicology and poision control centre munich, Klinikum rechts der Isar München, München, Germany.
Drugs of abuse and NPS poisoning
149 GHB overdose in nightlife settings and effectiveness of on-site harm-reduction organization
Miran Brvar, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Drugs of abuse and NPS poisoning
152 Acute intoxication with α-pyrrolidinohexanophenone, 4-fluoromethylphenidate and aminopropylbenzofuran complicated with rhabdomyolysis: a case report
Gambassi Francesco, Toxicology Unit and Poison Control Center, Careggi University Hospital, Florence, Italy.
Drugs of abuse and NPS poisoning
157 Characteristics of ecstasy toxicity in a Norwegian cohort of hospitalized poisoned patients
Per Sverre Persett, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
Drugs of abuse and NPS poisoning
324 A comparative analysis between acute ethanol poisoning and acute ethanol combined with drugs of abuse poisoning in adolescents
Viorela Nitescu, Pediatric Poisoning Centre Emergency Clinical Hospital for Children "Grigore Alexandrescu", Bucharest, Romania.
Drugs of abuse and NPS poisoning
325 Predicting hypertension using subjective symptoms in recreational drug users at first-aid stations at dance events
Yoram P Prins, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
Drugs of abuse and NPS poisoning
- Lunchtime Posters - Room 03
335 Favorable acute toxicity profile of the “hiking” stimulant nikethamide
Colette Degrandi, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
Pharmaceutical Poisoning
336 Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis
Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
Pharmaceutical Poisoning
337 “Reversal” of dabigatran-induced anticoagulation with idarucizumab: experience of an Italian hospital
Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
Pharmaceutical Poisoning
338 Metformin-related enquiries from hospitals to the National Poisons Information Service (NPIS) between 2010-2019: a comparison of metformin only and polypharmacy exposures
Bethan W Hughes, National Poisons Information Service, Cardiff, United Kingdom.
Pharmaceutical Poisoning
339 Characteristics of emergency department presentations following a drug suicide attempt
Mirjam Kummer, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Pharmaceutical Poisoning
340 Propylthiouracil administration in 5 cases of thyroid hormone intoxication
Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Pharmaceutical Poisoning
341 Evaluation of the overdosage section in Summaries of the Product Characteristics for medicines responsible for exposure calls to the Belgian Poison Centre
Jonas Moens, Belgian Poison Control Centre, Neder-Over-Heembeek, Belgium.
Pharmaceutical Poisoning
342 Is haem arginate safer in overdose than previously thought? An uneventful four-fold accidental overdose
Nandesh C Patel, National Poisons Information Service (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
Pharmaceutical Poisoning
- Lunchtime Posters - Room 04
065 Animal PoisonLine: review of a new public access veterinary poisons information service
Zoe Tizzard, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
066 Flurbiprofen toxicosis in dogs
Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
067 A retrospective study of cement exposure in 42 dogs
Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
068 Cases of botulism in waterfowls in the Po river valley
Carlo A. Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre, Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Veterinary toxicology (poisoning in animals)
383 Role of decontamination in dogs poisoned by alphachloralose-based rodenticides: a case series
Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
Veterinary toxicology (poisoning in animals)
384 “Curiosity killed the cat”: cats poisoned by alphachloralose containing rodenticides
Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
Veterinary toxicology (poisoning in animals)
385 A case series of hypothermic, sedated cats with sensory-induced CNS excitation: alphachloralose poisoning?
Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
Veterinary toxicology (poisoning in animals)
386 When does xylitol-induced hypoglycaemia occur in dogs?
Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
387 The effect of the COVID-19 pandemic on call numbers to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
388 The effect of the COVID-19 pandemic on animal poisons cases reported to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
Veterinary toxicology (poisoning in animals)
389 The successful treatment of thallium sulfate toxicity in a dog using Prussian blue
Anne Kan, Dutch Poisons Information Center, University Medical Center, Utrecht, Netherlands.
Veterinary toxicology (poisoning in animals)
- Lunchtime Posters - Room 05
005 Is lithium exposure responsible for brain injuries with prolonged treatment or? A rat investigation
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Mechanisms of Toxicity and Basic Research
009 Flurbiprofen toxicosis in dogs
Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
Epidemiology of poisoning
010 An analysis of cases of methaemoglobinaemia reported in telephone enquiries to the UK’s National Poisons Information Service (NPIS)
Victoria A Eagling, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Epidemiology of poisoning
017 Drug-induced death in the intensive care unit in France: what are the characteristics?
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Epidemiology of poisoning
023 Review of drug poisoning assessment at Emergency Department
Marieke A Dijkman, Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Epidemiology of poisoning
100 Poisoning in adolescents
Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
Epidemiology of poisoning
115 The ICU Requirement Score (IRS) - does it identify poisoned patients who do not need intensive care unit referral? A validation cohort study
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
VEpidemiology of poisoning
344 Comparison of acute kidney injury and renal replacement therapy in patients with rhabdomyolysis acutely intoxicated with psychotropic or chemical substances
Aleksandra Babulovska, Toxicology, University Clinic of Toxicology, Skopje, Macedonia.
(only available on May 27th)
Epidemiology of poisoning
345 Increasing enquiries to the Norwegian Poison Information Center (NPIC) concerning ozone
Marte S Evje, Norwegian Institute of Public Health, Norwegian Poison Information Centre, Oslo, Norway.
Epidemiology of poisoning
346 A 10-year review of ocular exposures reported to the Irish National Poisons Information Centre
Conor P Malone, National Health Library and Knowledge Service, HSE, Dublin, Ireland.
Epidemiology of poisoning
347 Fatalities due to acute poisoning: a one year retrospective study
Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”, Sofia, Bulgaria.
Epidemiology of poisoning
- Lunchtime Posters - Room 06
071 A 16 year (2002-2017) review of enquiries regarding plant abuse in Austria
Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
Plant and Mushroom Poisoning
072 A 16-year (2002-2017) review of suicide attempts by plant ingestion in Austria
Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
Plant and Mushroom Poisoning
091 Mistaking monkshood for radish resulting in a potentially fatal blood concentration of aconitine
Uwe Stedtler, Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany.
Plant and Mushroom Poisoning
092 Intoxication with castor beans
Marine Grigoryan, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Plant and Mushroom Poisoning
112 Mushroom poisonings in Finland: a 15-year retrospective study
Anne Tähkäpää, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki, Finland.
Epidemiology of poisoning
349 Lethal poisoning with Oenanthe crocata. Survive or not?
Marieke A Dijkman, Alexis Descatha, PCC, Ester Unit (IRSET U1085), Univ Angers- CHU Angers- Inserm, Angers, France.
Plant and Mushroom Poisoning
- Lunchtime Posters - Room 07
219 Clozapine-induced anemia: a case report
Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
Adverse reactions from medications
220 Lacosamide-induced recurrent ventricular fibrillation
Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
Adverse reactions from medications
222 Bleeding events due to warfarin therapy: how much does it cost?
Gabija Laubner, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania.
Adverse reactions from medications
223 Phenytoin intoxication associated with omeprazole administration in a child with CYP2C9 polymorphism
Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
Adverse reactions from medications
226 Olanzapine overdose-induced agranulocytosis
Gordana Vukovic Ercegovic, Department of Clinical Toxicology, National Poison Control Center, Military Medical Academy, Belgrade, Serbia.
(only available on May 27th)
Adverse reactions from medications
227 From kitchen to clinical use, to emergency department admission: an Italian story about curcumin
Francesco Gambassi, Toxicology Unit, Poison Control Center of Careggi University Hospital, Florence, Italy.
Adverse reactions from medications
229 Bowel perforation due to methotrexate therapeutic error: a case report.
Francesco Gambassi, Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Adverse reactions from medications
390 Pharmacovigilance for identification and prevention of therapeutic errors
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Adverse reactions from medications
391 Lamotrigine-induced Stevens-Johnson syndrome: a case report
Andrea Giampreti, Emergency Department, Poison Control Center, Bergamo, Italy.
Adverse reactions from medications
392 Dimethyl fumarate-induced hepatotoxicity confirmed by biopsy
Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
Adverse reactions from medications
- Lunchtime Posters - Room 08
001 Effect of ethanol coingestion in patients with central nervous system (CNS)-depressant intoxication
Eva-Carina Heier, Division of Clinical Toxicology and Poison Control Centre Munich, Department of Internal Medicine II, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Alcohol as a co-ingestant
031 Adults admitted to the emergency department of a university hospital in Belgium for acute poisoning with ethanol as a co-ingestant: characteristics and direct medical costs
Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
Alcohol as a co-ingestant
175 EXP3OP study: occupational eye exposures reported to a western France poison center
Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
Occupational poisoning
399 Severe gasoline poisoning and its treatment. The autonomy of the lung response facing different pathogenic agents
Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
Occupational poisoning
400 The health and blood aluminium concentration in firefighters following the Alytus tyre recycling factory fire
Gabija Laubner, Toxicology center, Republic Vilnius university hospital, Vilnius, Lithuania.
Occupational poisoning
401 A case of acute occupational exposure to sodium molybdate with determination of molybdenum concentration
Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Occupational poisoning
- Lunchtime Posters - Room 09
178 The role of CYP450 in the molecular toxicology of sulfur mustard in vitro
Presented By Simone Rothmiller, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Miscellaneous
181 “All right, I’ll be more careful next time”: frequent callers in Finnish Poison Information Centre (FPIC)
Suvi Pajarre-Sorsa, Poison Information Centre, Poison Information Centre, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland.
Miscellaneous
184 Risky dietary supplements: self-harm with potassium salt capsules
Sonny Larsson, Swedish Poison Information Centre, Solna, Sweden.
Miscellaneous
188 Supporting the establishment of an Ethiopian Poisons Centre
Ruben Thanacoody, National Poisons Information Service (Newcastle Unit), Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
Miscellaneous
192 Diphtheria: two cases treated with antitoxin
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Miscellaneous
363 Requests regarding snus to the Poisons Information Centre in Austria
Tara Arif, Poisons Information Centre, Vienna, Austria.
Miscellaneous
364 Multiple treatments of clotrimazole during pregnancy
Sian C D Harbon, National Poisons Information Service, Cardiff, United Kingdom.
Miscellaneous
365 Challenges facing the UK National Poisons Information Service (NPIS) ahead of EU Exit and commencement of Annex VIII of Article 45 (Classification, Labelling and Packaging)
Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
Miscellaneous
366 When volvulus hides a poisoning: a case of severe foodborne botulism
Roberto Zoppellari, Department of Anaesthesia and Intensive Care, S. Anna Hospital, Ferrara, Italy.
Miscellaneous
REST BREAK AND AUTHORS WITH POSTERS(AFTERNOON GROUPING)
- AFTERNOON Posters - Room 01
109 Non-medical use and injection use of prescription opioids in Europe in the Non-Medical Use of Prescription Drug (NMURx) National Surveys
Janetta L Iwanicki, Rocky Mountain Poison and Drug Safety, Denver, United States.
Drugs of abuse and NPS poisoning
118 Drug abuse trends, focussing on novel psychoactive substances (NPS) over the last three years (2016-2018) from the perspective of the Austrian Poisons Information Centre
Kinga Bartecka-Mino, Poisons Information Centre Austria, Vienna, Austria.
Drugs of abuse and NPS poisoning
122 A retrospective study of observation times in a healthcare facility and 48-hour mortality after heroin overdose with naloxone rescue
William Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
Drugs of abuse and NPS poisoning
127 Analysis of Twitter content to explore use of modafinil and methylphenidate as drugs to facilitate studying in the UK
David Wood, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Drugs of abuse and NPS poisoning
128 Non-medical use of prescription and over the counter opioids in the UK
David Wood, Clinical Toxicology, Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom.
Drugs of abuse and NPS poisoning
140 Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
Alison M Dines, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, United Kingdom.
Drugs of abuse and NPS poisoning
145 Mining and analysis of opioid content in longitudinal data posted in a social media forum
Jeanmarie Perrone, Emergency Medicine, University of Pennsylvania, Philadelphia, United States.
(only available on May 28th)
Drugs of abuse and NPS poisoning
156 Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Drugs of abuse and NPS poisoning
326 Acute recreational drug toxicity in Ghent, Belgium. Comparison of self-reports and analytical detection by immunoassay (IA) and mass spectrometry (MS) testing
Laurence Daveloose, Emergency medicine, UZ Ghent, Ghent, Belgium.
Drugs of abuse and NPS poisoning
327 In vino veritas: accidental MDMA poisoning by illicit drug trafficking
Katrin Faber, National Poisons Information Centre, Associated Institute of the University of Zurich, Zurich, Switzerland.
Drugs of abuse and NPS poisoning
328 Frequent hospitalization for synthetic cathinone poisonings: a case series reported to the Dutch Poisons Information Center
Johanna J Nugteren-Van Lonkhuyzen, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
Drugs of abuse and NPS poisoning
329 Exposures involving opioids and alcohol reported to the US Poison Centers
Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
Drugs of abuse and NPS poisoning
330 The Color Purple: death associated with brorphine, an emerging novel synthetic opioid
Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
Drugs of abuse and NPS poisoning - AFTERNOON Posters - Room 02
402 Acute poisoning in Moscow during COVID-19 restrictive measures
Anastasia Yu Simonova, Toxicological department, N.V. Sklifosovsky’ Research Institute of Emergency Medicine, Moscow, Russian Federation.
Covid-19 and toxicology
403 Unintended consequences of public health measures: exposures to alcohol-based hand sanitisers during the COVID-19 pandemic 2020
Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
Covid-19 and toxicology
404 Increased exposures to alcohol-based hand sanitizers reported by an Italian Poison Center during the COVID-19 pandemic
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Covid-19 and toxicology
405 Pediatric eye injuries related to public location of alcohol-based hand sanitizers during the first pandemic COVID-19 context: French Poison Control Centers data
Alexis Descatha, PCC, Ester Unit (IRSET U1085), UNIV Angers, CHU Angers, Univ Rennes, Inserm, EHESP, Irset,, Angers, France.
Covid-19 and toxicology
406 Has the COVID-19 pandemic changed the pattern of poisoning cases attending Emergency Departments?
Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
Covid-19 and toxicology
407 The only thing we have to fear is fear itself: inadvertent disopyramide toxicity during the COVID-19 pandemic
Emma R Furlano, Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, United States.
Covid-19 and toxicology
408 Nicotine does not affect SARS-CoV-2 in-host viral kinetics in a modeling and simulation study
Charlotte Kern, Department of General Internal Medicine, Clinical Pharmacology and Toxicology, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern; Graduate School for Health Sciences, University of Bern, Bern, Bern, Switzerland.
Covid-19 and toxicology
409 A human exposure to chlorine dioxide solution...not the solution
Valle Molina, Emergencie, Complejo Hospitalario de Navarra, pamplona, Spain.
Covid-19 and toxicology
410 Changes in the epidemiological profile of poisonings during COVID-19: differences between the first half of 2019 and 2020
Zanina Pereska, University Clinic of Toxicology, Skopje, Macedonia.
(only available on May 27th)
Covid-19 and toxicology
411 Multiple factors in a COVID-19 patient leading to an elevated 5-oxoproline as cause of high-anion gap metabolic acidosis: a case report
Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
Covid-19 and toxicology - AFTERNOON Posters - Room 03
200 Efficacy of a 12h intravenous acetylcysteine (SNAP) regimen following single acute paracetamol overdose
Ruben HK Thanacoody, National Poisons Information Service (Newcastle), Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Pharmaceutical Poisoning
239 Torsade de pointes following repeated massive loperamide ingestion
Aza Kader, Swedish Poisons Information Centre, Stockholm, Sweden.
Covid-19 and toxicology
247 Using “symptom search” to resolve an unusual case of poisoning reported to the UK National Poisons Information Service (NPIS)
Ho MR Lee, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
Pharmaceutical Poisoning
249 Different courses of quetiapine poisoning in two patients with gastric decontamination
Anne Stuerzebecher, Poisons Information Centre Erfurt, Erfurt, Germany.
Pharmaceutical Poisoning
261 Massive polypharmacy overdose resulting in diltiazem pharmacobezoar formation
David Goldberger, Emergency Medicine, Albert Einstein Medical Center, Philadelphia, United States.
Pharmaceutical Poisoning
- AFTERNOON Posters - Room 04
232 General characteristics of acute poisonings by hypotensive and antiarrhythmic drugs in Moscow, 2010-2017
Presented By Anastasia Yu Simonova, Moscow N.V.SklifosovskyResearch Institute of emergency medical Help, Poisonng teatment Center, Moscow, Russian Federation.
Pharmaceutical Poisoning
233 Acute toxicity profile of levomepromazine in overdose: a consecutive case series
Stefan Weiler, National Poisons Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
Pharmaceutical Poisoning
234 Be(a)ware of the fentanyl patch: unusual accidental cases of fentanyl intoxication
Marianne EC Leenders, National Poisons Information Center/Department of Anesthesiology, University Medical Center, Utrecht, Netherlands.
Pharmaceutical Poisoning
235 Calls to the Finnish Poison Information Centre related to drug poisoning in older people
Mervi Saukkonen, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
Pharmaceutical Poisoning
236 Preliminary experience with plasmapheresis instead of molecular adsorbent recirculating system as liver support for paracetamol-induced hepatic failure
Philippe Hantson, Intensive Care, Cliniques St-Luc, Université catholique de Louvain, Brussels, Belgium.
Pharmaceutical Poisoning
237 Acute poisoning with antihypertensive drugs: a retrospective study
Julia V Radenkova-Saeva, Clinic of Toxicology,, UMHATEM “N.I.Pirogov”, Sofia, Bulgaria.
Pharmaceutical Poisoning
238 Rectal overdose of paracetamol
Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
Pharmaceutical Poisoning
248 Favorable toxicity profile of escitalopram in acute overdose in adults
Katharina M Schenk-Jaeger, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
Pharmaceutical Poisoning
250 The association between phenytoin (diphenylhydantoin) and permanent cerebellar damage
Rachel Day, National Poisons Information Service, Birmingham Centre, Birmingham, United Kingdom.
Pharmaceutical Poisoning
343 Literature review of antidotal carbapenem use in valproic acid toxicity
William Rushton, Alabama Poison Information Center, Children's of Alabama, Birmingham, United States.
Pharmaceutical Poisoning
- AFTERNOON Posters - Room 05
103 Mass acute thallium poisoning treated with enteral detoxification using Prussian blue and gut lavage
Anastasyja Yu Simonova, N.V.Sklifosovsky Rtesearch Institute of Emergency Medicine, Poisonings Treatment Department, Moscow, Russian Federation..
Heavy Metal Poisoning
162 Arsenic exposure and peripheral neuropathy
Chay J Markham, Cardiff University, Cardiff, United Kingdom.
Heavy Metal Poisoning
163 Gadolinum contrast media: old substance, new challenges
Gabija Mikuleviciene, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania
Heavy Metal Poisoning
165 Comparison of unithiol (DMPS) treatment effect in two patients with severe cobalt intoxication
Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
Heavy Metal Poisoning
168 Toxicokinetics of silver and chelation unithiol (DMPS) challenge tests in argyria due to colloidal silver
Gasper Razinger, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
PHeavy Metal Poisoning
412 An unsolved mystery: idiopathic thallium exposure resulting in clinically significant toxic effects
Varun Vohra, Emergency Medicine, Michigan Poison Center at Wayne State University School of Medicine, Detroit, United States.
Heavy Metal Poisoning
- AFTERNOON Posters - Room 06
070 Suicidal Cerbera odollam poisoning: a case report
Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
Plant and Mushroom Poisoning
081 A severe and prolonged case of Amanita phalloides poisoning
Anja J Huusom, Department of Occupational and Environmental Medicine, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
Plant and Mushroom Poisoning
085 Facial paralysis after cutaneous burns from Heracleum mantegazzianum
Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Plant and Mushroom Poisoning
088 Does combining vitamin C and vitamin B17 (amygdalin) worsen toxicity?
Faisal S Minhaj, Maryland Poison Center, Baltimore, United States.
Plant and Mushroom Poisoning
089 Confusion between toxic and edible plants registered by the French Poison Control Centres from 2012 to 2018
Sandra Sinno-Tellier, Health Alerts and Vigilance department, French Agency for Food, Environmental and Occupational Health & Safety, MAISONS-ALFORT, France.
Plant and Mushroom Poisoning
090 Acute poisoning due to Datura ingestion: case report
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Plant and Mushroom Poisoning
093 Severe plant poisonings admitted to the intensive care in France: management and outcome
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Plant and Mushroom Poisoning
105 Toxicological evaluation of a cluster of reports of hepatitis related to turmeric dietary supplements in Italy
Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Miscellaneous
350 The White Panther: rare exposure to Amanita multisquamosa causing clinically significant toxicity
Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
Plant and Mushroom Poisoning
- AFTERNOON Posters - Room 07
008 Portal embolism in hydrogen peroxide ingestion: a case series
Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Household Products Poisoning
051 Artificial nail primer: a case series from Pavia Poison Control Centre
Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Household Products Poisoning
052 Nail glue: a beauty hazard
Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
Household Products Poisoning
353 Accidental exposures to caustic drain cleaners
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Household Products Poisoning
354 The “lactate gap” as a useful tool to detect ethylene glycol intoxications
Dieter Geysels, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
Household Products Poisoning
355 A one-year review of enquiries to the UK National Poisons Information Service involving cosmetic products
Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
Household Products Poisoning
356 Acute ethylene glycol poisoning: a one year epidemiological study
Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”,, Sofia, Bulgaria.
Household Products Poisoning
357 Button battery ingestion: experience of the UK National Poisons Information Service (NPIS)
Simon H L Thomas, National Poisons Information Service (Newcastle Unit), Regional Drugs and Therapeutics Centre, Newcastle upon Tyne, United Kingdom.
Household Products Poisoning
- AFTERNOON Posters - Room 08
035 Amitraz: an unfamiliar insecticide with familiar toxicity
William Rushton, Office of Medical Toxicology, University of Alabama at Birmingham, Birmingham, United States.
Pesticide Poisoning
040 The impact of obidoxime on duration of hospitalization in acute organophosphate poisoning in Muratsan University Hospital, Yerevan, Armenia, 2012-2019
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Pesticide Poisoning
041 Poisoning risk of acute exposures to repellents: results from a prospective observational study
Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
Pesticide Poisoning
043 Organophosphate poisoning among children and adolescents in Armenia: a retrospective case study
Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Pesticide Poisoning
044 Lethal intoxication by pentachlorophenol
Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Pesticide Poisoning
360 Evaluation of biocidal product enquiries to the Austrian Poisons Information Centre, 2017
Tara Arif, Poisons Information Centre, Vienna, Austria.
Pesticide Poisoning
- AFTERNOON Posters - Room 09
224 Two case of opioid withdrawal syndrome precipitated by alcohol dependence treatment with nalmefene successfully treated with morphine
Jonas Moens, Belgian Poison Centre, Brussels, Belgium.
Adverse reactions from medications
228 Accidental injection of pseudorabies pigs vaccine in humans
Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Adverse reactions from medications
393 Iodoform medications may cause iodine toxicosis: two case reports
Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Adverse reactions from medications
394 Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
Adverse reactions from medications
395 Symptomatic therapeutic errors in the elderly: a case study
Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Adverse reactions from medications
396 Severe adverse effects after a second dose of paliperidone palmitate long-acting injectable administration: a case report
Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Adverse reactions from medications
397 Soft capsules formulated with ethanol: unexpected disulfiram-ethanol reaction after one dosage of ciclosporin
Jonas Moens,Belgian Poison Control Centre, NEDER-OVER-HEEMBEEK, Belgium.
Adverse reactions from medications
398 Effect of a 12-hour intravenous acetylcysteine (SNAP) regimen on the International Normalized Ratio (INR)
Ruben Thanacoody, Newcastle University, Newcastle Upon Tyne, United Kingdom.
Adverse reactions from medications
- AFTERNOON Posters - Room 10
058 Sticky eye: a pediatric case of cyanoacrylate ocular exposure
Presented By Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Spain.
Paediatric Poisoning
063 Pediatric cannabis poisonings in France: more and more frequent and severe.
Gaël Le Roux, >Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
Paediatric Poisoning
371 Childhood poisonings: five-years’ experience from an Italian pediatric emergency department
Andrea Giampreti, Bergamo Poison Control Center, ASST Papa Giovanni XXIII, Bergamo, Italy.
Paediatric Poisoning
372 Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
Adverse reactions from medications
373 Altered mental status following a large ondansetron ingestion in a toddler
Vincent Calleo, Emergency Medicine, SUNY Upstate Medical University, Syracuse, United States.
Paediatric Poisoning
374 Severe salicylic acid intoxication with a topical skin preparation in a newborn
Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
Paediatric Poisoning
375 38 Weeks pregnant: managing a mother and neonate after a third-trimester acetaminophen ingestion
Charlotte Goldfine, Emergency Medicine, Brigham and Women's Hospital, Boston, United States.
Paediatric Poisoning
376 Epidemiology of pediatric benzodiazepines exposures using the National Poison Data System
Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
Paediatric Poisoning
- AFTERNOON Posters - Room 11
104 Long-term exposure to Sargassum-seaweed pollution in the French Caribbean Islands: clinical consequences and outcome
Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
Epidemiology of poisoning
284 Latrodectus tredecemguttatus poisoning: a case report treated with antidote
Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
Toxinology (bites, stings, antivenom etc)
285 Prolonged neurological effects after delayed antivenin administration
Alfred Aleguas, Poison Information Center-Tampa, Tampa General Hospital, Tampa, United States.
Toxinology (bites, stings, antivenom etc)
286 Cardiovascular complications following ciguatera fish poisoning in the French West Indies: a case series
Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
Toxinology (bites, stings, antivenom etc)
287 Epidemiology of bites by indigenous venomous snakes in Switzerland reported to Tox Info Suisse over a 22 year period
Joan Fuchs, Swiss National Poisons Information Center, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
Toxinology (bites, stings, antivenom etc)
289 An analysis of envenoming features in adder bite cases referred to the UK National Poisons Information Service (NPIS)
David Stewart, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Toxinology (bites, stings, antivenom etc)
290 Kambô: a healing potion or a poisonous toxin?
Annie Watt, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Toxinology (bites, stings, antivenom etc)
291 Viper bite neurotoxicity: two pediatric cases in central Italy
Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
Toxinology (bites, stings, antivenom etc)
292 Thromboelastogram use in Crotalus adamanteus envenomation
William F Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
Toxinology (bites, stings, antivenom etc)
381 Rattlesnake bite in Austria: a case report
Susanna Dorner-Schulmeister, Poisons Information Centre, Vienna, Austria.
Toxinology (bites, stings, antivenom etc)
382 Bitten abroad, an unforgettable souvenir: bites and stings reported to the UK National Poisons Information Service (NPIS) sustained whilst travelling overseas, 2009-2019
Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
Toxinology (bites, stings, antivenom etc)
- AFTERNOON Posters - Room 12
185 Valproic acid in the management of delirious, agitated critically ill toxicology patients
Joseph J Rasimas, Consultation - Liaison Psychiatry, Hennepin County Medical Center, Minneapolis, United States.
Miscellaneous
186 Takotsubo syndrome during benzodiazepine withdrawal: a case report
Francesco Gambassi, Medical Toxicology Unit and Poison Control Center, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
Miscellaneous
191 Myocardial infarction in the acutely poisoned patient: a case series
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Miscellaneous
193 QTc interval and electrolyte derangement in alcohol withdrawal-related seizures
Agnesa Mustafa, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Miscellaneous
203 Emergent toxicological molecular screening test on ICU admission: can it be trusted?
Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
Analytical and Forensic Toxicology - including bedside testing
211 The value of post-mortem toxicology in deciding whether a death is drug-induced
James M Coulson, Clinical Pharmacology, Cardiff University, Cardiff, United Kingdom.
Analytical and Forensic Toxicology - including bedside testing
216 Laboratory practice variations complicate poison centre recommendations for massive paracetamol overdose
Timothy C Backus, NYU School of Medicine, New York, United States.
Analytical and Forensic Toxicology - including bedside testing
218 Poison center recommendations for methylxanthine toxicity may be complicated by limited access to theophylline measurements
Timothy C Backus, NYU School of Medicine, New York, United States.
Analytical and Forensic Toxicology - including bedside testing
361 Biological sample collection in the emergency department and laboratory substance abuse investigation and confirmation: a methamphetamine case report
Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Analytical and Forensic Toxicology - including bedside testing
362 Post-mortem ethanol concentrations
James M Coulson, All Wales Therapeutics & Toxicology Centre, Cardiff University, Cardiff, United Kingdom.
Analytical and Forensic Toxicology - including bedside testing